Acumen Pharmaceuticals has dosed the first patient in the ALTITUDE-AD Phase II trial for its lead drug sabirnetug (ACU193).

Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE: SNDA), a leading owner-operator and investor in communities and ...

I n the dim hours of a recent Wednesday night, a remarkable demonstration of combat capability was captured by a Ukrainian ...

Josh Manson had his best offensive season in six years, then continued a strong postseason with a huge save in Game 1 for the ...

Marketing manager extraordinaire, Padraig O’Connor navigates the world of marketing with perseverance, innovation, and ...

Mike Budenholzer is the frontrunner to replace Frank Vogel as coach of Phoenix Suns, but frontrunners don't always land the ...

Navigating the ever-shifting tides of the cryptocurrency market requires a keen eye for patterns and a bold willingness to ...

ATAS is an online casino with a PAGCOR license in Malaysia. This online login casino has proven to be absolutely re ...

Börje Ekholm, President and CEO of Ericsson, commented: “Fadi has contributed immensely to Ericsson with his deep knowledge ...

Arsen Tomsky is an underdog in more ways than one.

At a Thursday luncheon, Gulfshore Business honored ten women for making a difference in the business community, the nonprofit ...